Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder

被引:179
作者
Schloesser, Robert J.
Huang, Jian
Klein, Peter S.
Manji, Husseini K.
机构
[1] NIMH, NIH, Lab Mol Pathophysiol Mood Anxiety & Disorders Pro, Bethesda, MD 20892 USA
[2] Univ Penn, Sch Med, Dept Med Hematol Oncol, Philadelphia, PA USA
关键词
bipolar disorder; neuroplasticity; intracellular signaling cascades; lithium; valproic acid; mood stabilizer;
D O I
10.1038/sj.npp.1301575
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Bipolar disorder ( BPD) is characterized by recurrent episodes of disturbed affect including mania and depression as well as changes in psychovegetative function, cognitive performance, and general health. A growing body of data suggests that BPD arises from abnormalities in synaptic and neuronal plasticity cascades, leading to aberrant information processing in critical synapses and circuits. Thus, these illnesses can best be conceptualized as genetically influenced disorders of synapses and circuits rather than simply as deficits or excesses in individual neurotransmitters. In addition, commonly used mood-stabilizing drugs that are effective in treating BPD have been shown to target intracellular signaling pathways that control synaptic plasticity and cellular resilience. In this article we draw on clinical, preclinical, neuroimaging, and post-mortem data to discuss the neurobiology of BPD within a conceptual framework while highlighting the role of neuroplasticity in the pathophysiology and treatment of this disorder.
引用
收藏
页码:110 / 133
页数:24
相关论文
共 244 条
  • [1] Synaptic defects and compensatory regulation of inositol metabolism in inositol polyphosphate 1-phosphatase mutants
    Acharya, JK
    Labarca, P
    Delgado, R
    Jalink, K
    Zuker, CS
    [J]. NEURON, 1998, 20 (06) : 1219 - 1229
  • [2] The Bcl-2 protein family: Arbiters of cell survival
    Adams, JM
    Cory, S
    [J]. SCIENCE, 1998, 281 (5381) : 1322 - 1326
  • [3] ALTSHULER LL, 1995, AM J PSYCHIAT, V152, P1139
  • [4] Does long-term medication with lithium, clozapine or antidepressants prevent or attenuate dementia in bipolar and depressed patients?
    Angst, Jules
    Gamma, Alex
    Gerber-Werder, Regina
    Zarate, Carlos A., Jr.
    Manji, Husseini K.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (01) : 2 - 8
  • [5] Glycogen synthase kinase-3 is required for optimal de novo synthesis of inositol
    Azab, Abed N.
    He, Quan
    Ju, Shulin
    Li, Guiling
    Greenberg, Miriam L.
    [J]. MOLECULAR MICROBIOLOGY, 2007, 63 (04) : 1248 - 1258
  • [6] BAASTRUP PC, 1967, ARCH GEN PSYCHIAT, V16, P162
  • [7] Mood stabilizers target cellular plasticity and resilience cascades - Implications for the development of novel therapeutics
    Bachmann, RF
    Schloesser, RJ
    Gould, TD
    Manji, HK
    [J]. MOLECULAR NEUROBIOLOGY, 2005, 32 (02) : 173 - 202
  • [8] BAUM AE, 2007, MOL PSYCHIAT 0508
  • [9] Reduced volume of limbic system-affiliated basal ganglia in mood disorders: Preliminary data from a postmortem study
    Baumann, B
    Danos, P
    Krell, D
    Diekmann, S
    Leschinger, A
    Stauch, R
    Wurthmann, C
    Bernstein, HG
    Bogerts, B
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1999, 11 (01) : 71 - 78
  • [10] Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology
    Baumann, B
    Danos, P
    Krell, D
    Diekmann, S
    Wurthmann, C
    Bielau, H
    Bernstein, HG
    Bogerts, B
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 1999, 54 (1-2) : 217 - 224